Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THDB0206 PK/PD at Different Injection Sites in Healthy Adults
NCT07257627Phase 1Completed
- Sponsor
- Tonghua Dongbao
- Start
- Apr 2024
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of BioChaperone Lispro in diabetes mellitus (DM), sponsored by Tonghua Dongbao. Primary endpoint: Area Under the Curve of Insulin Lispro from 0 to Infinity. Started Apr 2024; status: completed.
02
Drugs
BioChaperone Lispro
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT07257627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07257627.